JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2008, 57(1):29-34

Substances Modifying the Activity of Caspases

T. Bartl*, P. Žádníková, R. Jiříkovská, B. Maroušková, L. Beneš
Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav chemických léčiv

Caspases are enzymes which play a key role in programmed cell death - apoptosis. Dysregulation of this process results in a series of disorders in which apoptosis is involved in pathogenesis. Diseases could be divided into two groups - diseases with pathological inhibition of apoptosis (cancer, some autoimmune disorders) and diseases with pathological induction of apoptosis (neurodegenerative disorders, AIDS). The paper lists the most significant activators and inhibitors of caspases as they control apoptosis and hence they are widely studied nowadays. The effects of stobadine, theophylline and adenine derivatives on the activity of caspase 1 was investigated with the use of spectrophotometry. The compounds under study showed an inhibitory effect on the enzyme tested; in one case the inhibitory effect exceeded 80%.

Keywords: caspases; apoptosis; derivatives of stobadine, theophylline, adenine

Received: October 18, 2007; Accepted: November 29, 2007; Published: January 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartl T, Žádníková P, Jiříkovská R, Maroušková B, Beneš L. Substances Modifying the Activity of Caspases. Čes. slov. farm. 2008;57(1):29-34.
Download citation

References

  1. Russell, S. W., Rosenau, W., Lee, J. C.: Am. J. Pathol., 1972; 69, 103-118.
  2. Bózner, A., Fízel, A., Kopáčová, L. et al.: Farmakologická propedeutika, 1. vyd. Bratislava, Osveta, 1984; 277, 278.
  3. https://www.zdravcentra.cz, staženo 5. 1. 2007.
  4. Rosypal, S.: Úvod do molekulární biologie, 1. vyd. Blansko, Grafex, 1999; 485-488.
  5. http://www.fnplzen.cz/, staženo 11. 2. 2007.
  6. Steller, H.: Science, 1995; 267, 1445-1449. Go to original source... Go to PubMed...
  7. Jacobson, M. D., Weil, M., Raff, M. C.: Cell, 1997; 88, 347-354. Go to original source... Go to PubMed...
  8. Cohen, J. J.: Immunol. Today, 1993; 14, 126-130. Go to original source... Go to PubMed...
  9. Trauth, B. C., Keesey, J.: Cell death. In: Trauth, B. C. Boehringer Mannheim, 1998; 34-61.
  10. Rudin, C. M., Thompson, C. B.: Annu. Rev. Med., 1997; 48, 267-281. Go to original source... Go to PubMed...
  11. Riedl, S. J., Shi, Y.: Nat. Rev. Mol. Cell Biol., 2004; 5, 897-907. Go to original source... Go to PubMed...
  12. Li, P., Nijhawan, D., Budihardjo, I. et al.: Cell, 1997; 91, 479-489. Go to original source... Go to PubMed...
  13. Reed, J. C.: Am. J. Pathol., 2000; 157, 1415-1431. Go to original source... Go to PubMed...
  14. Green, D. R., Kroemer, G.: J. Clin. Invest., 2005; 115, 2610-2617. Go to original source... Go to PubMed...
  15. Varfolomeev, E. E., Ashkenazi, A.: Cell, 2004; 116, 491-497. Go to original source... Go to PubMed...
  16. Chinnaiyan, A. M.: Neoplasia, 1999; 1, 5-15. Go to original source... Go to PubMed...
  17. Yan, N., Shi, Y.: Annu. Rev. Cell Dev. Biol., 2005; 21, 35-56. Go to original source... Go to PubMed...
  18. Philchenkov, A.: J. Cell Mol. Med., 2004; 8, 432-444. Go to original source... Go to PubMed...
  19. Ho, P. K., Hawkins, C. J.: FEBS Lett., 2005; 272, 5436-5453. Go to original source... Go to PubMed...
  20. Yuan, J. Y., Shaham, S., Ledoux, S. et al.: Cell, 1993; 75, 641-652. Go to original source... Go to PubMed...
  21. Twomey, C., McCarthy, J. V.: J. Cell Mol. Med., 2005; 9, 345-359. Go to original source... Go to PubMed...
  22. Fan, T. J., Han, L. H., Cong, R. S., Liang, J.: Acta Biochim. Biophys. Sinica, 2005; 37, 719-727. Go to original source... Go to PubMed...
  23. Wolf, B. B., Green, D. R.: J. Biol. Chem., 1999; 274, 20049-20052. Go to original source... Go to PubMed...
  24. Degterev, A., Boyce, M., Yuan, J. Y.: Oncogene, 2003; 22, 8543-8567. Go to original source... Go to PubMed...
  25. Shi, Y.: Mol. Cells, 2002; 9, 459-470. Go to original source... Go to PubMed...
  26. Fuentes-Prior, P., Salvesen, G. S.: Biochem. J., 2004; 384, 201-232. Go to original source... Go to PubMed...
  27. Lavrik, I. N., Golks, A., Krammer, P. H.: J. Clin. Invest., 2005; 115, 2665-2672. Go to original source... Go to PubMed...
  28. http://is.muni.cz/ staženo 9. 2. 2007.
  29. Jin, Z. Y., El-Deiry, W. S.: Cancer Biol. Ther., 2005; 4, 139-163. Go to original source... Go to PubMed...
  30. Thompson, C. B.: Science, 1995; 267, 1456-1462. Go to original source... Go to PubMed...
  31. http://ustavpatologie.upol.cz, staženo 15. 2. 2007.
  32. Chwajol, B.: Urologie pro praxi, 2001; 3, 119-121.
  33. http://www.sukl.cz/, staženo 14. 2. 2007.
  34. Hideshima, T., Chauhan, D., Podar, K. et al.: Semin. Oncol., 2001; 28, 607-612. Go to original source...
  35. http://www.chem-online.org/generic-pharmaceutical, staženo 19. 2. 2007.
  36. Oancea, M., Mani, A., Hussein, M. A., Almasan, A.: Int. J. Hematol., 2004; 80, 224-231. Go to original source... Go to PubMed...
  37. Ückert, S., Hedlund, P., Andersson, K. E. et al.: Eur. Urol., 2006; 50, 1194-1207. Go to original source... Go to PubMed...
  38. Klener, P.: Sanquis, 2004; 36, 14-16.
  39. http://redpoll.pharmacy.ualberta.ca, staženo 14. 2. 2007.
  40. Graczyk, P. P.: Restor. Neurol. Neurosci., 1999; 14, 1-23.
  41. Bonuccelli, U., Del Dotto, P.: Neurology, 2006; 67, 30-38. Go to original source... Go to PubMed...
  42. Loher, F., Bauer, C., Landauer, N. et al.: J. Pharmacol. Exp. Ther., 2004; 308, 583-590. Go to original source... Go to PubMed...
  43. http://merops.sanger.ac.uk, staženo 27. 2. 2007.
  44. Concha, N. O., Abdel-Meguid, S. S.: Current Med. Chem., 2002; 9, 713-726. Go to original source... Go to PubMed...
  45. Beneš, L., Pronayová, N.: Pharmazie, 1994; 49, 69-70.
  46. Návody firmy Calbiochem: Calbiochem User Protocol, No. 218783.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.